Joseph Charles Deflore is categorized under Orthopedic Doctors and Physicians in Knoxville, TN and active since 2001.
Joseph Charles Deflore was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Joseph C Deflore J at the company’s single location by writing to 1128 East Weisgarber Road, Knoxville, Tennessee TN 37909 or by phoning (865) 558-4400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Joseph Charles Deflore |
Contact Person: | Joseph C Deflore J |
Address: | 1128 East Weisgarber Road, Knoxville, Tennessee 37909 |
Phone Number: | (865) 558-4400 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Orthopedic Doctors and Physicians |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Joseph Charles Deflore was started in 2001 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Joseph C Deflore J for inquiries that concern Joseph Charles Deflore by calling the company number (865) 558-4400, as your correspondence is most welcome. Additionally, the physical location of the single location of Joseph Charles Deflore can be found at the coordinates 35.945325,-84.012698 as well as the street address 1128 East Weisgarber Road in Knoxville, Tennessee 37909.
For its online presence, you may visit Joseph Charles Deflore’s website at and engage with its social media outlets through on Twitter and on Facebook.